Israel Lyophilized Injectable Drugs Market to 2032
Overview
The Israel Lyophilized Injectable Drugs Market is expected to reach a 9.17 USD Million by 2032 and is projected to grow at a CAGR of 4.26% from 2025 to 2032.
Revenue, 2024 (USD Million)
7.14
Forecast, 2032 (USD Million)
9.17
CAGR, 2024 - 2032
4.26%
Report Coverage
Israel
Israel Lyophilized Injectable Drugs Market 2018-2032 USD Million
Israel Lyophilized Injectable Drugs Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 7.14 USD Million
- Projected Market Size (2032): 9.17 USD Million
- CAGR (2025-2032): 4.26%
Key Findings of Israel Lyophilized Injectable Drugs Market
- The Israel Lyophilized Injectable Drugs Market was valued at 7.14 USD Million in 2024.
- The Israel Lyophilized Injectable Drugs Market is likely to grow at a CAGR of 4.26% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Powder in Form Segment accounted for the largest share of the market with a revenue of 6.70 USD Million
- The fastest growing segment Hospital in End User Segment grew Fastest with a CAGR of 5.85% during the forecast period from 2024 to 2032.
Israel Lyophilized Injectable Drugs Market Scope
Israel Lyophilized Injectable Drugs Market Segmentation & Scope
Distribution Channel
- Others
- Retail Sales
- Direct Tenders
End User
- Others
- Home Healthcare
- Clinics
- Hospital
Route of Administration
- Others
- Intramuscular
- Intravenous/Infusion
Indication
- Others
- Ophthalmic Diseases
- Dermatological Disorders
- Gastrointestinal Disorders
- Respiratory Diseases
- Hormonal Disorders
- Autoimmune Diseases
- Oncology
Drug Class
- Others
- Corticosteroids
- Nsaid’s
- Anticoagulant
- Anesthetic
- Proton Pump Inhibitor
- Diuretics
- Antineoplastic
- Anti-Infective’s
Form
- Liquid
- Powder
Packaging
- Others
- Dual-Chamber Cartridges
- Dual-Chamber Syringes
- Vials
Israel Lyophilized Injectable Drugs Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 7.14 USD Million |
| Market Value in 2032 | 9.17 USD Million |
| CAGR (2025-2032) | 4.26% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End User,Route of Administration,Indication,Drug Class,Form,Packaging |
Regional Insights:
-
Leading Market (2024-2032): Israel, leading in terms of revenue 7.14 USD Million in 2024
- Key Country: Israel, leading in terms of revenue with value of 7.14 USD Million in 2024.
Segments and Scope
-
Israel Lyophilized Injectable Drugs Market to 2032, By Distribution Channel
- Direct Tenders is the largest segment in Israel Lyophilized Injectable Drugs Market to 2032 with a revenue of 6.06 USD Million in the year 2024.
- Direct Tenders is the Fastest growing segment in Israel Lyophilized Injectable Drugs Market to 2032 with a Growth rate of 4.48 % in forecast period 2025-2032.
-
Israel Lyophilized Injectable Drugs Market to 2032, By End User
- Hospital is the largest segment in Israel Lyophilized Injectable Drugs Market to 2032 with a revenue of 2.77 USD Million in the year 2024.
- Hospital is the Fastest growing segment in Israel Lyophilized Injectable Drugs Market to 2032 with a Growth rate of 5.85 % in forecast period 2025-2032.
-
Israel Lyophilized Injectable Drugs Market to 2032, By Route of Administration
- Intravenous/Infusion is the largest segment in Israel Lyophilized Injectable Drugs Market to 2032 with a revenue of 5.34 USD Million in the year 2024.
- Intravenous/Infusion is the Fastest growing segment in Israel Lyophilized Injectable Drugs Market to 2032 with a Growth rate of 5.11 % in forecast period 2025-2032.
-
Israel Lyophilized Injectable Drugs Market to 2032, By Indication
- Oncology is the largest segment in Israel Lyophilized Injectable Drugs Market to 2032 with a revenue of 3.82 USD Million in the year 2024.
- Oncology is the Fastest growing segment in Israel Lyophilized Injectable Drugs Market to 2032 with a Growth rate of 5.26 % in forecast period 2025-2032.
-
Israel Lyophilized Injectable Drugs Market to 2032, By Drug Class
- Anti-Infective’s is the largest segment in Israel Lyophilized Injectable Drugs Market to 2032 with a revenue of 3.33 USD Million in the year 2024.
- Anti-Infective’s is the Fastest growing segment in Israel Lyophilized Injectable Drugs Market to 2032 with a Growth rate of 5.83 % in forecast period 2025-2032.
-
Israel Lyophilized Injectable Drugs Market to 2032, By Form
- Powder is the largest segment in Israel Lyophilized Injectable Drugs Market to 2032 with a revenue of 6.70 USD Million in the year 2024.
- Powder is the Fastest growing segment in Israel Lyophilized Injectable Drugs Market to 2032 with a Growth rate of 4.51 % in forecast period 2025-2032.
-
Israel Lyophilized Injectable Drugs Market to 2032, By Packaging
- Vials is the largest segment in Israel Lyophilized Injectable Drugs Market to 2032 with a revenue of 5.19 USD Million in the year 2024.
- Vials is the Fastest growing segment in Israel Lyophilized Injectable Drugs Market to 2032 with a Growth rate of 4.52 % in forecast period 2025-2032.
Israel Lyophilized Injectable Drugs Market Company Share Analysis
| Company Name |
|
||
| Merck & Co., Inc. | |||
| Novartis AG | |||
| Zydus Group | |||
| Pfizer Inc. | |||
| Baxter | |||
Israel Lyophilized Injectable Drugs Market Geographical Sales Distribution, 2018-2032 USD Million
Israel Lyophilized Injectable Drugs Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Israel Lyophilized Injectable Drugs Market is segmented based on Segmentation Distribution Channel,End User,Route of Administration,Indication,Drug Class,Form,Packaging.
Israel Lyophilized Injectable Drugs Market was valued at USD 7.14(Revenue in USD Million) in 2020.
Israel Lyophilized Injectable Drugs Market is projected to grow at a CAGR of 4.26% during the forecast period of 2024 to 2032.
The Powder segment is expected to dominate the Israel Lyophilized Injectable Drugs Market, holding a largest market share of 6.70 USD Million in 2024
Israel Lyophilized Injectable Drugs Market Scope
Israel Lyophilized Injectable Drugs Market Segmentation & Scope
Distribution Channel
- Others
- Retail Sales
- Direct Tenders
End User
- Others
- Home Healthcare
- Clinics
- Hospital
Route of Administration
- Others
- Intramuscular
- Intravenous/Infusion
Indication
- Others
- Ophthalmic Diseases
- Dermatological Disorders
- Gastrointestinal Disorders
- Respiratory Diseases
- Hormonal Disorders
- Autoimmune Diseases
- Oncology
Drug Class
- Others
- Corticosteroids
- Nsaid’s
- Anticoagulant
- Anesthetic
- Proton Pump Inhibitor
- Diuretics
- Antineoplastic
- Anti-Infective’s
Form
- Liquid
- Powder
Packaging
- Others
- Dual-Chamber Cartridges
- Dual-Chamber Syringes
- Vials
Frequently Asked Questions
The Israel Lyophilized Injectable Drugs Market is segmented based on Segmentation Distribution Channel,End User,Route of Administration,Indication,Drug Class,Form,Packaging.
Israel Lyophilized Injectable Drugs Market was valued at USD 7.14(Revenue in USD Million) in 2020.
Israel Lyophilized Injectable Drugs Market is projected to grow at a CAGR of 4.26% during the forecast period of 2024 to 2032.
The estimated market value of the Israel Lyophilized Injectable Drugs Market for final year is USD 9.17 (USD Million).
Israel Lyophilized Injectable Drugs Market Company Profiling
Frequently Asked Questions
The Israel Lyophilized Injectable Drugs Market is segmented based on Segmentation Distribution Channel,End User,Route of Administration,Indication,Drug Class,Form,Packaging.
Israel Lyophilized Injectable Drugs Market was valued at USD 7.14(Revenue in USD Million) in 2020.
Israel Lyophilized Injectable Drugs Market is projected to grow at a CAGR of 4.26% during the forecast period of 2024 to 2032.
The estimated market value of the Israel Lyophilized Injectable Drugs Market for final year is USD 9.17 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.